Synchrony 2019 Presentations
The microbiome and autism – basic research to clinical trials
Sarkis Mazmanian, PhD
Luis and Nelly Soux Professor of Microbiology, Caltech
Antipurinergic therapy to address core disabilities of ASD
Robert Naviaux, MD, PhD
UCSD
Microbiota Transfer Therapy for Children with ASD and GI disorders: Summary of Phase 1 and Follow-Up
James Adams, PhD
Rosa Krajmalnik Brown, PhD
ASU
Brain Plasticity in ASD
Michael Merzenich, PhD
Professor (Emeritus), UCSF
CSO, Posit Science Corporation
CSO, Stronger Brains
Genomic Testing in Autism Spectrum Disorder
David Bick, MD
Chief Medical Officer & Faculty Investigator,
Hudson Alpha Institute for Biotechnology
A new evidence-based method for choosing the most effective treatments for autism
Daniel Rossignol, MD, FAAFP
Rossignol Medical Center
The End ME/CFS Project
Ronald W. Davis, PhD
Professor of Biochemistry and Genetics,
Director of the Stanford Genome Technology Center
Stanford University School of Medicine
Collaborative Care in ABA Treatment for Autism
Dennis Dixon, PhD
Chief Clinical Officer at the Center for Autism and Related Disorders (CARD)
Disruption of Brain development and function by Folate Receptor Antibodies: Treatment of Autism Spectrum Disorders
Edward Quadros, PhD
Research Professor at SUNY
Mitochondrial Medicine and Autism
Richard Boles, MD
Mitochondrial and Molecular Medicine
Seizures and Epilepsy in Autism Spectrum Disorder
Richard Frye, MD, PhD
Chief of the Division of Neurodevelopment Disorders and Director of the Autism Program at Phoenix Children’s Hospital
Autism-Associated Enterocolitis Treatment Study
Arthur Krigsman, MD
Pediatric Gastroenterologist




















If you have questions please contact us at register@brainfoundation.org